As people have said, a reverse split in the biotech space is usually associated with weakness. Not the case here, but often the case. And it often results in a droop in sp. For that reason people are conditioned to fear it. For that reason bashers often billboard an upcoming reverse split on Yahoo. So people are conditioned to be pissed at anyone talking about it.
But maybe it would be a good idea right now for this company.
Let's say they had great news tomorrow, or at the Oct 8-12 at the CNS Summit in Florida. Let's say the SP went to $4 or $17 (wth) in two days. It might be weeks before they would be uplisted due to the all the processing. Not sure how long it takes... but if it takes weeks or months, then by the time they were uplisted the feeding frenzy might be over with the big dogs never having had a chance to compete for shares. That would not be in our interest because we want volume that matches the importance of the good news. Volume that eats through the remaining warrants, funding the company, and then continues afterwards, elevating the share price.
So... a reverse split now might avoid that. They could uplist prior to news. Or... as someone just posted, maybe an uplist to the NYSE would solve that delay problem. IMUC is in the NYSE. Hell, if they can qualify, we could qualify now!
News 
Market Data 
Discover 
